iCAD Releases ClearLook(TM) - CAD Image Characterization Package

iCAD Releases ClearLook(TM) - CAD Image Characterization Package

NASHUA, N.H., Dec. 22 /PRNewswire-FirstCall/ -- iCAD, Inc. (NASDAQ:ICAD), which designs, develops and markets Computer Aided Detection (CAD) imaging technology and systems for the early detection of breast cancer and other medical applications, today announced the release of its ClearLook(TM) CAD Image Characterization Package. ClearLook is used together with iCAD's Radiologist Review Station, which presents breast images marked to show suspicious features on a display screen typically located where mammographic films are read.

ClearLook offers full-image high-resolution zoom capabilities to allow the radiologist to enlarge any area of the breast image presented. ClearLook provides the radiologist descriptive data related to masses and calcifications in the region of interest, helping the radiologist understand why a particular set of features was marked, or not marked, in a CAD study. The ClearLook package, available as an option for the company's Second Look 500(TM) Mammographic CAD systems, will also be available as an option on iCAD's recently announced, category-defining Second Look 300(TM) system for early detection of breast cancer.

"Because ClearLook provides enhanced viewing and hard data related to the pathology in question," said Scott Parr, iCAD's President & CEO, "it provides additional support to the physician in recognizing and addressing early indicators of breast cancer. This is a feature our customers have requested," continued Parr, "and we feel we have responded with a superior tool for use in interpretation of screening mammograms.

About iCAD, Inc.

iCAD engineers, develops, manufactures and markets computer aided detection (CAD) products for the early detection of breast cancer and other health-care related applications. Selected for the third time as the "Winning Combination of User Satisfaction and Price" by MD Buyline, and this year's recipient of Frost & Sullivan's "Growth Strategy Leadership Award," iCAD is the only independent, integrated digitizer hardware and CAD software company offering computer aided detection solutions. As such, iCAD is able to reduce costs at each step in the CAD product design, production and assembly process. The Company believes its vertical integration of CAD and hardware development results in better integration of software and film digitizer components, lower production costs and reduced administrative overhead. These achievements have allowed iCAD to progressively enhance its CAD product line, while reducing the costs of CAD to many customers and allowing more women to realize the benefits inherent in the early detection of breast cancer. More information on iCAD's products can be found at www.icadmed.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's other filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The company is under no obligation to provide any updates to any information contained in this release.

For more information on iCAD, Inc., contact, Kevin McGrath at

(212) 245-4577 or via email at kevin@cameronassoc.com


Source: iCAD, Inc.

CONTACT: Kevin McGrath, +1-212-245-4577, kevin@cameronassoc.com, for
iCAD, Inc.

Web site: http://www.icadmed.com/


-------
Profile: intent